Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. [electronic resource] by
- Arellano, Martha
- Pakkala, Suchita
- Langston, Amelia
- Tighiouart, Mourad
- Pan, Lin
- Chen, Zhengjia
- Heffner, Leonard T
- Lonial, Sagar
- Winton, Elliott
- Khoury, H Jean
Producer: 20130131
In:
Cancer vol. 118
Availability: No items available.
|
|
|
13.
|
|
|
|
14.
|
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond. [electronic resource] by
- Lima, Lisa
- Bernal-Mizrachi, Leon
- Saxe, Debra
- Mann, Karen P
- Tighiouart, Mourad
- Arellano, Martha
- Heffner, Leonard
- McLemore, Morgan
- Langston, Amelia
- Winton, Elliott
- Khoury, Hanna Jean
Producer: 20110512
In:
Cancer vol. 117
Availability: No items available.
|
|
|
15.
|
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. [electronic resource] by
- Tran, Ha
- Arellano, Martha
- Chamsuddin, Abbas
- Flowers, Christopher
- Heffner, Leonard T
- Langston, Amelia
- Lechowicz, Mary Jo
- Tindol, Allen
- Waller, Edmund
- Winton, Elliott F
- Khoury, Hanna J
Producer: 20101116
In:
Leukemia & lymphoma vol. 51
Availability: No items available.
|
|
|
16.
|
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years. [electronic resource] by
- Arellano, Martha
- Winton, Elliott
- Pan, Lin
- Lima, Lisa
- Tighiouart, Mourad
- Bhalla, Kapil
- Heffner, Leonard T
- Neely, Jessica
- Hutcherson, Donald
- McLemore, Morgan
- Langston, Amelia
- Khoury, H Jean
Producer: 20120228
In:
Cancer vol. 118
Availability: No items available.
|
|
|
17.
|
Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia? [electronic resource] by
- Lima, Lisa M
- Sampat, Keeran
- Assouline, Sarit
- Saxe, Debra
- Nault, Sharron
- Tighiouart, Mourad
- McLemore, Morgan
- Arellano, Martha
- Winton, Elliott
- Bernal-Mizrachi, Leon
- Cortes, Jorge
- Khoury, Hanna Jean
Producer: 20111024
In:
Leukemia & lymphoma vol. 52
Availability: No items available.
|
|
|
18.
|
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib. [electronic resource] by
- Kota, Vamsi K
- Kong, Jee Hyun
- Arellano, Martha
- El Rassi, Fuad
- Gaddh, Manila
- Heffner, Leonard T
- Winton, Elliott F
- Jillella, Anand P
- McLemore, Morgan L
- Khoury, H Jean
Producer: 20180709
In:
Clinical lymphoma, myeloma & leukemia vol. 17
Availability: No items available.
|
|
|
19.
|
A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias. [electronic resource] by
- Lancet, Jeffrey E
- Duong, Vu H
- Winton, Elliott F
- Stuart, Robert K
- Burton, Michelle
- Zhang, Shumin
- Cubitt, Christopher
- Blaskovich, Michelle A
- Wright, John J
- Sebti, Said
- Sullivan, Daniel M
Producer: 20110912
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
|
20.
|
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial. [electronic resource] by
- Harrison, Claire N
- Vannucchi, Alessandro M
- Platzbecker, Uwe
- Cervantes, Francisco
- Gupta, Vikas
- Lavie, David
- Passamonti, Francesco
- Winton, Elliott F
- Dong, Hua
- Kawashima, Jun
- Maltzman, Julia D
- Kiladjian, Jean-Jacques
- Verstovsek, Srdan
Producer: 20180807
In:
The Lancet. Haematology vol. 5
Availability: No items available.
|